Interestingly, the intermediate, non-penetrative expansion size in ATXN2 has been associated with other diseases, specifically amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) [87]. The gene discussed is ATXN2; the disease is amyotrophic lateral sclerosis.